# A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).

> **NCT00380796** · — · COMPLETED · sponsor: **Centocor, Inc.** · enrollment: 88 (actual)

## Conditions studied

- COPD
- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Collection of safety data for Cohort 1

## Key facts

- **NCT ID:** NCT00380796
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2013-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380796, "A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00380796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*